Cargando…

A Prospective Trial in Saudi Arabia Comparing the 14-day Standard Triple Therapy with the 10-day Sequential Therapy for Treatment of Helicobacter pylori Infection: A Further Confirmation of “Geographic Weight”

Detalles Bibliográficos
Autores principales:	Losurdo, Giuseppe, Iannone, Andrea, Giorgio, Floriana, Ierardi, Enzo, Di Leo, Alfredo, Principi, Mariabeatrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763533/ https://www.ncbi.nlm.nih.gov/pubmed/26831611 http://dx.doi.org/10.4103/1319-3767.173763

Ejemplares similares

Role of concomitant therapy for Helicobacter pylori eradication: A technical note
por: Losurdo, Giuseppe, et al.
Publicado: (2016)

Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?
por: Ierardi, Enzo, et al.
Publicado: (2017)

The Puzzle of Coccoid Forms of Helicobacter pylori: Beyond Basic Science
por: Ierardi, Enzo, et al.
Publicado: (2020)

Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis
por: Losurdo, Giuseppe, et al.
Publicado: (2018)

Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness
por: Ierardi, Enzo, et al.
Publicado: (2019)

Rifabutin as salvage therapy for Helicobacter pylori eradication: Cornerstones and novelties
por: Borraccino, Antonia Valeria, et al.
Publicado: (2022)

New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study
por: Iannone, Andrea, et al.
Publicado: (2018)

Prospective Trial in Saudi Arabia Comparing the 14-day Standard Triple Therapy with the 10-day Sequential Therapy for Treatment of Helicobacter Pylori Infection
por: Alsohaibani, Fahad, et al.
Publicado: (2015)

Biological markers for non-celiac gluten sensitivity: a question awaiting for a convincing answer
por: Ierardi, Enzo, et al.
Publicado: (2018)

Helicobacter pylori Primary and Secondary Genotypic Resistance to Clarithromycin and Levofloxacin Detection in Stools: A 4-Year Scenario in Southern Italy
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease
por: Ranaldo, Nunzio, et al.
Publicado: (2017)

Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg?
por: Giorgio, Floriana, et al.
Publicado: (2015)

Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm
por: Losurdo, Giuseppe, et al.
Publicado: (2018)

Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control Study
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model
por: Girardi, Bruna, et al.
Publicado: (2020)

Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study
por: Losurdo, Giuseppe, et al.
Publicado: (2018)

The Spectrum of Small Intestinal Lesions in Patients with Unexplained Iron Deficiency Anemia Detected by Video Capsule Endoscopy
por: Contaldo, Antonella, et al.
Publicado: (2019)

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial
por: Liou, Jyh-Ming, et al.
Publicado: (2016)

Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial
por: Hajiani, Eskandar, et al.
Publicado: (2018)

Inter-Observer Agreement of a New Endoscopic Score for Ulcerative Colitis Activity: Preliminary Experience
por: Principi, Mariabeatrice, et al.
Publicado: (2020)

Seven‐day vonoprazan‐based triple therapy as first‐line Helicobacter pylori treatment in comparison with extended sequential therapy
por: Chiu, Yu‐Tse, et al.
Publicado: (2023)

Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?
por: Ierardi, Enzo, et al.
Publicado: (2017)

Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

The State of the Art of Molecular Fecal Investigations for Helicobacter pylori (H. pylori) Antibiotic Resistances
por: Celiberto, Francesca, et al.
Publicado: (2023)

Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea
por: Kim, Beom Jin, et al.
Publicado: (2019)

Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?
por: Abadi, Amin Talebi Bezmin, et al.
Publicado: (2019)

Seronegative celiac disease: where is the specific setting?
por: Ierardi, Enzo, et al.
Publicado: (2015)

Seven Days of Bismuth-Based Quadruple Therapy Is as Effective for the First-Line Treatment of Clarithromycin-Resistant Confirmed Helicobacter pylori Infection as 14 Days of Bismuth-Based Quadruple Therapy
por: Moon, Sang-Gon, et al.
Publicado: (2022)

Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy
por: Losurdo, Giuseppe, et al.
Publicado: (2022)

Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population
por: Principi, Mariabeatrice, et al.
Publicado: (2018)

Effect of Visual Booklets to Improve Bowel Preparation in Colonoscopy: Systematic Review with Meta-Analysis
por: Losurdo, Giuseppe, et al.
Publicado: (2023)

Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia
por: Chan, Chung-Chuan, et al.
Publicado: (2015)

Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes?
por: Licinio, Raffaele, et al.
Publicado: (2014)

Furazolidone-based Therapies for Helicobacter pylori Infection: A Pooled-data Analysis
por: Zullo, Angelo, et al.
Publicado: (2012)

May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis?
por: Losurdo, Giuseppe, et al.
Publicado: (2016)

Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

T Helper Lymphocyte and Mast Cell Immunohistochemical Pattern in Nonceliac Gluten Sensitivity
por: Losurdo, Giuseppe, et al.
Publicado: (2017)

The cost-effectiveness of sequential versus standard triple therapy for Helicobacter pylori eradication in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2021)

Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
por: Lee, Seong tae, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_320i5pk96frf5jj6frd2c2mk79